TENX

Conviction 4HealthcareScan · Thu, Sep 24, 2026

Tenax Therapeutics, Inc. (TENX) closed at $1.90 (-0.26%) on Sep 24, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 29, RS Rating 10, -89.7% from its 52-week high, -82.8% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

TENX$1.90-0.26%

ResistanceSupportVol 14Insider buy

Vol MA14 4.01M

Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24

TENAX THERAPEUTICS, INC.PHARMACEUTICAL PREPARATIONSwww.tenaxthera.com ↗

Price1.90

Change-0.26%

Gap-0.53%

Rel volume0.88×

Avg volume5.05M

Avg $ vol9.62M

SMA 201.92

SMA 506.23

SMA 20011.44

Price vs 50-69.60%

Price vs 200-83.43%

MA stackbearish

50/200 cross—

Supertrenddown · 2.48

RSI (14)29

MACD hist0.35

MACD cross—

Stoch %K / %D23 / 30

ADX (14)42

+DI / −DI17 / 39

RSI divergence—

MACD divergence—

ATR %16.69%

ADR %7.38%

52w high18.32

52w low1.38

From 52w high-89.66%

Above 52w low+37.82%

New 52w highNo

SqueezeOn · 1d

Bollinger width23.02%

%B0.45

Donchian pos29.45%

Donchian high2.29

Donchian low1.73

AVWAP (52w high)3.09

vs AVWAP high-38.67%

AVWAP (52w low)1.78

vs AVWAP low+6.30%

OBV trendDown

Chaikin MF (20)-0.27

Today vs 20d0.88×

Avg vol (14d)4.01M

Avg vol (20d)5.05M

Avg $ vol (20d)9.62M

Market cap70.92M

RS Rating10 / 99

RS 3m (vs SPY)-89.79%

RS 6m (vs SPY)-103.28%

RS line new highNo

Trend template1/8

Technical rank8.4

1 week+1.88%

1 month-18.32%

3 months-85.30%

6 months-86.46%

1 year-70.98%

YTD-82.85%

P/E-1.35

P/B0.62

P/S—

P/FCF-1.98

EPS-1.34

Div yield—

ROE-46.31%

ROA-43.23%

Debt/Eq—

Current15.07

EV/EBITDA0.83

Gross margin—

Net margin—

Rev growth—

EPS growth-198.82%

Price target9.63

Target upside408.18%

Analyst ratingBuy

Institutional86.87%

Ent. value-47.08M

Revenue0

Net income-17.8M

Gross profit0

Free cash flow-35.8M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out26.53M

Employees16

ListedWed, Feb 1, 1995

Free float5.59M

Float %89.6%

Short interest9.28M

Days to cover1.1d

Short volume49.8%

Squeeze score52 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.35 vs −$0.38

Last surprise+7.9% beat

Setup gradeD

Conviction4 / 100

Pattern quality—

Tech rank8.4 / 100

Group rank59 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance8.34

Support1.45

Days since event—

Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in TENX

All disclosures →

No recent disclosed trades by Congress in TENX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in TENX · open-market 10 buys

Insider	Side	Shares	Value	Traded	Filed
Doogan Declan Director · Common Stock · 2026-09-16	Buy	53K	$102K	2026-09-16	2026-09-17
Giordano Christopher Thomas CEO · Common Stock · 2026-09-15	Buy	4.85K	$9K	2026-09-15	2026-09-15
Giordano Christopher Thomas CEO · Common Stock · 2026-09-11	Buy	6K	$11K	2026-09-11	2026-09-15
STAAB THOMAS R II Chief Financial Officer · Common Stock · 2026-09-11	Buy	5.67K	$11K	2026-09-11	2026-09-15
ADAR1 Capital Management, LLC 10% owner · Common Stock · 2026-09-03	Buy	900K	$1.6M	2026-09-03	2026-09-08
ADAR1 Capital Management, LLC 10% owner · Common Stock · 2026-09-02	Buy	187.7K	$338K	2026-09-02	2026-09-02
ADAR1 Capital Management, LLC 10% owner · Common Stock · 2026-09-01	Buy	179.06K	$322K	2026-09-01	2026-09-02
ADAR1 Capital Management, LLC 10% owner · Common Stock · 2026-08-31	Buy	403.57K	$723K	2026-08-31	2026-09-02
ADAR1 Capital Management, LLC 10% owner · Common Stock · 2026-08-24	Buy	107.37K	$188K	2026-08-24	2026-08-24
ADAR1 Capital Management, LLC 10% owner · Common Stock · 2026-08-21	Buy	716.37K	$1.3M	2026-08-21	2026-08-24

SEC filings

EDGAR filings in TENX · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.